Melanotan II: Tanning, Dosage, and Safety

Melanotan II is the tanning peptide, and it has a reputation that runs ahead of the actual evidence. People know it as the injection that makes you go dark faster than the sun ever would, and that part is broadly true. What gets less attention is that it activates several melanocortin receptors at once, which is why it also blunts appetite and drives libido, and why the safety picture is more complicated than a simple cosmetic shortcut. This is a practical breakdown of how it works, how it is dosed, what side effects to actually expect, and where the real risks sit.

What Melanotan II Is

Melanotan II (often written MT2 or Melanotan 2) is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH), the hormone your body uses to signal melanin production. It was originally developed at the University of Arizona in the 1980s as part of research into a "sunless tanning" agent that might reduce skin cancer risk by encouraging protective pigmentation without heavy UV exposure. The original medical program did not carry the compound through to approval, and what circulates today in the research chemical market is the same molecule sold for laboratory use only.

Regulatory status: Melanotan II is not FDA approved and not approved by the EMA. It is not a licensed medicine anywhere. Regulators including the UK's MHRA and Australia's TGA have specifically warned against unlicensed tanning injections. When people buy it, they are buying a research compound with no pharmaceutical quality guarantee, which is a meaningful part of the risk story.

How It Actually Works

Your skin color at any moment is driven by melanocytes, the cells that produce the pigment melanin. Alpha-MSH binds the melanocortin-1 receptor (MC1R) on those cells and tells them to switch from lighter pheomelanin toward darker eumelanin. Melanotan II mimics that signal, but far more potently and for longer than the natural hormone, so a given amount of stimulation produces a much stronger pigment response.

The important nuance most marketing skips: the peptide primes the machinery, but ultraviolet light is still the trigger. Most users find they need some sun or controlled UV exposure to actually develop the tan. What the peptide changes is the ratio, you get a deeper tan from far less UV, which is the theoretical safety argument in its favor. It does not make you tan in a dark room.

Because Melanotan II is not selective for MC1R alone, it also hits MC3R and MC4R. Those receptors sit in pathways governing appetite and sexual function, which is the mechanistic reason a tanning peptide also suppresses hunger and produces erections. That off-target activity is not a bug people found later, it is baked into the molecule.

The Loading and Maintenance Protocol

Melanotan II protocols almost universally split into two phases. The logic is that you build pigment aggressively at first, then do the minimum needed to hold it.

Loading phase

The loading phase runs a small daily dose until you reach the color you want. A common conservative starting point is 250 micrograms subcutaneously per day, taken in the evening because that tends to reduce the perceived nausea. Many people never go above 500 micrograms daily. Reaching target pigmentation typically takes one to three weeks and depends heavily on skin type. Fair, red-haired, freckle-prone skin (Fitzpatrick type 1 to 2) responds slower and burns easier, so those users specifically should go slower, not faster.

Maintenance phase

Once you are at your target color, the dose drops sharply. Maintenance is usually 500 to 1000 micrograms once or twice per week, adjusted by how the tan holds. The tan fades over weeks if you stop entirely, similar to a natural tan, because pigmented cells turn over.

Reconstitution matters here. Melanotan II ships as a lyophilized powder and has to be mixed with bacteriostatic water before use, then kept refrigerated. If you have not done this before, our peptide reconstitution guide and the reconstitution calculator walk through the math so you are dosing what you think you are dosing. Getting the concentration wrong is the single most common reason people accidentally take far too much and get slammed with nausea.

Side Effects: The Honest List

Melanotan II is one of the more side-effect-heavy peptides in common use, precisely because of its multi-receptor activity. The frequently reported effects include:

• Nausea, mostly in the first days and after dose increases. Evening dosing and starting low are the standard ways people manage it.
• Facial flushing and a warm feeling shortly after injection.
• Appetite suppression, sometimes significant. Some users treat this as a bonus, but it is a real physiological effect worth planning around.
• Spontaneous erections in men, driven by MC4R activity. This is dose-related and one of the more predictable effects.
• Darkening of moles and new freckles. All melanocytes respond, not just the ones you want. This is cosmetically expected but medically the biggest reason for caution.

The mole issue deserves its own emphasis. Because Melanotan II darkens existing moles and can prompt new pigmented spots, it can mask, mimic, or make it harder to notice the early visual changes that signal melanoma. Anyone using it should have a baseline skin check and should get any mole that changes size, shape, border, or color evaluated by a dermatologist. That is not a boilerplate caution, it is the specific risk that separates this peptide from most others.

The Real Safety Concerns

Two things drive the genuine risk with Melanotan II, and neither is the tan itself.

First is product quality. Because it is sold as a research chemical, there is no regulatory floor on purity, sterility, or accurate dosing. Reports of injection-site reactions and infections usually trace back to poor product or poor injection technique rather than the molecule. Sourcing from vendors that publish batch-specific certificates of analysis is the main lever an individual actually controls.

Second is the melanoma masking problem described above, combined with the fact that the long-term systemic effects of chronic melanocortin receptor activation are not well characterized in humans. There are case reports in the dermatology literature of changing moles and new melanocytic lesions in users. The compound has never been through the large, long-term safety trials that an approved drug would require, so the honest answer on long-term safety is that it is unknown.

None of this is a recommendation. It is the information a person would need to weigh the decision themselves, and the decision genuinely warrants a conversation with a clinician, especially for anyone with fair skin, a family history of skin cancer, or a lot of moles.

Melanotan II vs Melanotan I

People conflate the two, but they behave differently. Melanotan I, also called afamelanotide, is a linear peptide that is more selective for MC1R. It is actually approved in some regions under the brand name Scenesse to protect patients with erythropoietic protoporphyria, a rare disorder of extreme light sensitivity. Because it is more selective, Melanotan I produces fewer of the libido and appetite effects.

Melanotan II is the cyclic, more potent, less selective cousin. It tans faster and harder and is what almost everyone means by "the tanning peptide," but that potency comes with the broader side effect profile. If the only goal were pigmentation with fewer off-target effects, Melanotan I is the more targeted molecule, though it is far less available on the research market.

Where It Fits Alongside Other Peptides

Melanotan II sits in the cosmetic corner of the peptide world, closer to skin and appearance compounds than to the recovery or metabolic peptides most of this site covers. If your interest is skin quality rather than tanning specifically, collagen and skin-focused compounds are a different route entirely, our GHK-Cu guide and the peptides for skin and hair roundup cover those. People drawn to Melanotan II for its libido effect sometimes also look at PT-141 (bremelanotide), which is a closely related melanocortin peptide developed specifically for sexual function, and which is actually FDA approved for that indication. And because appetite suppression comes up so often, it is worth being clear that Melanotan II is not a weight-loss tool, the dedicated weight-loss peptides like the GLP-1 class are a separate and far better-studied category.

Sourcing Melanotan II

The single most important sourcing rule with this compound is batch documentation. Since there is no regulatory quality floor, a certificate of analysis showing purity and identity is the closest thing to a safety net. A few of the vendors we track carry it:

• Apollo Peptides stocks Melanotan II with batch certificates, and is generally a reliable option to compare on price.
• Pantheon Peptides also carries Melanotan II with published lab results per batch.
• Amino Club lists Melanotan II as a separate vial with documentation, at competitive pricing.

Whichever vendor you use, buy the lyophilized powder, store it correctly, and reconstitute with bacteriostatic water. Cost is generally modest compared to therapeutic peptides, a single vial usually lasts through a loading phase and well into maintenance.

Key Takeaways

• Melanotan II is a synthetic alpha-MSH analog that stimulates melanin production, tanning you faster and darker from less UV exposure.
• UV light is still the trigger, the peptide amplifies the response rather than replacing the sun.
• Standard protocol: a low daily loading dose (250 to 500mcg) until target color, then 500 to 1000mcg once or twice weekly for maintenance.
• Common side effects: nausea, flushing, appetite suppression, spontaneous erections in men, and darkening of moles and freckles.
• The biggest real risk is that it can mask early melanoma signs, so baseline and ongoing skin checks matter.
• It is not FDA or EMA approved and is sold only as a research chemical, so product quality varies and long-term safety is uncharacterized.
• Melanotan I (afamelanotide) is more selective and approved in some regions, but far less available.
• Source only from vendors that publish batch-specific certificates of analysis.

Frequently Asked Questions